Jupiter Neurosciences, Inc. share price logo

Jupiter Neurosciences, Inc.

NASDAQ: JUNS

$2.79

+0.21

(+8.14%)

Live

as on

Jupiter Neurosciences, Inc. Stock Performance

as on October 24, 2026 at 6:24 am IST

  • Day's Low

    Day's High

    $2.63
    $2.81
    downward going graph

    5.73%

    Downside

    0.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.25
    $135.75
    downward going graph

    19.32%

    Downside

    4765.59%

    Upside

    downward going graph

Jupiter Neurosciences, Inc. share price movements today

Previous Close
$2.58
Open
$2.63
Volume
171.9K
Market Cap
$3.7M
Day's Low - High
$2.63 - $2.81
52 Week Low - High
$2.25 - $135.75

Jupiter Neurosciences, Inc. Historical Returns

1 Month Return
-13.13 %
3 Month Return
-77.52 %
1 Year Return
-97.68 %
3 Year Return
0 %
5 Year Return
0 %

Jupiter Neurosciences, Inc. Stock Fundamentals & Key Indicators

Check Jupiter Neurosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7M

EPS (TTM)

-19.3275

Dividend Yield

0.00%

PE Ratio (TTM)

-0.14

Industry PE ratio

-2.60

PEG Ratio

0.00

Return On Equity TTM

747.33%

Jupiter Neurosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jupiter Neurosciences, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$3.7MNA-0.1488.34%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Jupiter Neurosciences, Inc. Stock including INR - Dollar returns

The Jupiter Neurosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Jupiter Neurosciences, Inc. investment value today

Current value as on today

₹2,719

Returns

-₹97,281

(-97.28%)

Returns from Jupiter Neurosciences, Inc. Stock

-₹97,486 (-97.49%)

Dollar Impact

₹205 (+0.21%)

Indian Investors' Interest in Jupiter Neurosciences, Inc. Stock

Search interest for Jupiter Neurosciences, Inc. Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-76% versus previous 30 day period

Jupiter Neurosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
0
0
0
Gross Profit
-
-
-
-
-
-
-
0
0
0
Operating Income
0
0
0
-1
-1
-2
-2
-2
-1
-2
EBITDA
0
0
0
-1
-1
-2
-2
-2
-1
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
-
-
-
-
-
-
-
-
0
Income Before Tax
0
0
0
-1
-1
-2
-2
-2
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
0
-1
-1
-2
-2
-2
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
76.61%
86.88%

Jupiter Neurosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
1
0
0
-
-
0
Gross Profit
-
1
0
0
-
-
0
Operating Income
-2
-1
-3
-3
-3
-3
-8
EBITDA
-2
-1
-4
-4
-4
-2
-8
Interest Expense
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-3
-1
-4
-4
-4
-2
-8
Income Tax Expense
-
-
0
-
-
-
-
Net Income
-3
-1
-4
-4
-4
-2
-8
Net Profit Margin
0.00%
100.00%
100.00%
100.00%
0.00%
0.00%
80.59%

Jupiter Neurosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
0
-1
-1
-2
-2
6
-2
-2
Operating Cash Flow
0
0
0
-3
-1
0
-1
-2
-1
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
7
-
-
-
5
0
1
Change in Cash
0
0
0
3
-1
0
-1
3
-1
0

Jupiter Neurosciences, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-1
-4
-4
-4
-2
-8
Operating Cash Flow
0
0
-1
-1
0
-3
-5
Investing Cash Flow
-
-
-
-
-
-
-
Financing Cash Flow
0
0
1
0
0
7
5
Change in Cash
0
0
0
0
0
3
0

Global Institutional Holdings in Jupiter Neurosciences, Inc.

Check out the Institutions with significant holdings in Jupiter Neurosciences, Inc..

Funds
Holdings
VANGUARD INSTITUTIONAL INDEX FUNDS
15.08%
VANGUARD INDEX FUNDS
12.22%
Fidelity Concord Street Trust
9.68%
Vanguard
0.13%

Jupiter Neurosciences, Inc. News & Key Events

  • img

    Today's Timeline - 21 July

    Wed, 02:16 AM

    -

    Jupiter Neurosciences secures exclusive U.S. license for ALA-002 from PharmAla, involving significant milestone payments and royalties.

Insights on Jupiter Neurosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 769.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, JUNS stock has moved down by -11.2%

About Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
OrganisationJupiter Neurosciences, Inc.
Headquarters1001 North US HWY 1, Jupiter, FL, 33477, US
IndustryBiotechnology
CEOChrister Rosen

Key Management of Jupiter Neurosciences, Inc.

Name

Title

Mr. Alexander Rosen

Co-Founder & Chief Administrative Officer

Mr. Saleem Elmasri CPA

CFO & Secretary

Dr. Claes Wahlestedt M.D., Ph.D.

Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

Mr. Christer Rosen

Co-Founder, CEO & Chairman of the Board

Ms. Alison D. Silva MA, MS

President, COO & Director

Dr. Marshall Hayward Ph.D.

Co-Founder, Chief Scientific Officer & Director

FAQs

What is Jupiter Neurosciences, Inc. share price today?

Jupiter Neurosciences, Inc. share price today is $2.79 as on . Jupiter Neurosciences, Inc. share today touched a day high of $2.81 and a low of $2.63.

What is the 52 week high and 52 week low for Jupiter Neurosciences, Inc. share?

Jupiter Neurosciences, Inc. share touched a 52 week high of $135.75 on and a 52 week low of $2.25 on . Jupiter Neurosciences, Inc. stock price today i.e. is trending at $2.79,which is 97.94% down from its 52 week high and 23.94% up from its 52 week low.

What is Jupiter Neurosciences, Inc.'s market capitalisation today?

Jupiter Neurosciences, Inc. market capitalisation is $0.00T as on .

How to invest in Jupiter Neurosciences, Inc. Stock (JUNS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jupiter Neurosciences, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Jupiter Neurosciences, Inc. Stock (JUNS) from India?

Indian investors can start investing in Jupiter Neurosciences, Inc. (JUNS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Jupiter Neurosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Jupiter Neurosciences, Inc. share’s latest price of $2.79 as on October 24, 2026 at 12:54 am IST, you will get 3.5842 shares of Jupiter Neurosciences, Inc.. Learn more about fractional shares .